• 1030
  • 0
  • 2
  • 0
  • Help Ukraine

Diabetic Karin Hehenberger created Lyfebulb to reduce the burden of living with chronic disease through the power of the patient.

Shared by Joana Santos Afonso on 2023-11-10 20:34

About the solution

Lyfebulb, founded by Karin Hehenberger, stands as an innovative company dedicated to improving the lives of those grappling with chronic diseases, particularly exemplified by Hehenberger's personal journey with type 1 diabetes. The company's commitment to patient-centric solutions is evident in its development of advanced glycemic monitoring devices, offering individuals with diabetes a more accessible and precise means of disease management. Additionally, Lyfebulb's interactive digital platforms foster collaboration between patients and healthcare professionals, enabling a more informed and cooperative approach to chronic condition management.

Beyond technological innovations, Lyfebulb's impact extends to personalized educational programs designed to empower patients with comprehensive information for effective self-management of chronic diseases. These initiatives, coupled with innovative mobile applications facilitating symptom monitoring and treatment plan adherence, showcase Lyfebulb's holistic commitment to enhancing the quality of life for individuals facing chronic health challenges.

Lyfebulb's significance transcends product development; the company actively forges strategic partnerships with healthcare organizations and pharmaceutical companies. These collaborations aim to drive continuous research and development, introducing novel therapies and technologies to advance the global landscape of chronic disease care. In this way, Lyfebulb, under the inspiring leadership of Karin Hehenberger, serves as a beacon of how personal experiences can propel ventures that make a lasting and positive impact on the lives of those managing chronic health conditions.

For more information go to: https://lyfebulb.com/karins-story/

This solution shall not include mention to the use of drugs, chemicals or biologicals (including food); invasive devices; offensive, commercial or inherently dangerous content. This solution was not medically validated. Proceed with caution! If you have any doubts, please consult with a health professional.

DISCLAIMER: This story was written by someone who is not the author of the solution, therefore please be advised that, although it was written with the utmost respect for the innovation and the innovator, there can be some incorrect statements. If you find any errors please contact the patient Innovation team via info@patient-innovation.com

About the author

Dr. Karin Hehenberger is the founder of Lyfebulb. Diagnosed with type 1 diabetes at an early age, Dr. Hehenberger has dedicated her life to helping others impacted by chronic illnesses. Her personal history with diabetes as well as its consequences, which required kidney and pancreas transplants, provide Dr. Hehenberger with an understanding from a patient perspective as well as a medical professional. It is from those experiences both as a patient and as a doctor, that Dr. Hehenberger was motivated to create Lyfebulb.

Like solution
Close en
Close